Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to ...

Medtronic (NYSE:MDT), which has operations worldwide, is reportedly looking at adjusting its manufacturing footprint amid ...

After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...

Wealthspire Advisors LLC lessened its stake in shares of Medtronic plc (NYSE:MDT – Free Report) by 40.6% during the 4th ...

Medtronic, a leader in medical technology and Philips, a leader in health technology announced the signing of a Memorandum of ...

The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with ...

Brainomix announced today that it entered into a strategic partnership with the Medtronic Neurovascular business unit.

ViCentra announced today that it appointed Tom Arnold as its new CEO to accelerate growth with the Kaleido automated insulin ...

The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...

Shares of Medtronic ( MDT -6.63%) were sinking 7.3% as of 11:21 a.m. ET on Tuesday. The decline came after the medical device ...

Dr Michalis Papadakis, CEO and Co-Founder of Brainomix, highlighted the shared vision of both companies: “This partnership ...

The revenue miss came as sales at Medtronic's Medical Surgical division declined 1.9% to $2.07 billion. The company pointed ...